President and CEO
Andy Eibling has 35 years of leadership experience in the pharmaceutical, CRO and medtech industries focused on business and corporate development. Prior roles include Vice President of Business Development and Alliance Management at Enable Injections, and Vice President of Enterprise Alliance Management at Covance. He began his career at Eli Lilly and Company, spending nearly 25 years in multiple roles of increasing responsibility. Mr. Eibling has a BS in Mechanical Engineering from Purdue University, and an MBA from Indiana University.